Azzad Asset Management Inc /Adv Sarepta Therapeutics, Inc. Transaction History

Azzad Asset Management Inc /Adv

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Apr 01, 2024	SELL	$100.86 - $132.13 $147,860 - $193,702	-1,466 Closed	0 $0
Q2 2022 Apr 01, 2024	BUY	$62.69 - $88.44 $91,903 - $129,653	1,466 New	1,466 $235 Million
Q3 2020 Apr 01, 2024	SELL	$127.12 - $172.34 $186,357 - $252,650	-1,466 Closed	0 $0
Q2 2020 Apr 01, 2024	BUY	$93.0 - $171.7 $136,338 - $251,712	1,466 New	1,466 $235 Million
Q1 2020 Apr 01, 2024	SELL	$82.38 - $131.64 $241,538 - $385,968	-2,932 Closed	0 $0
Q3 2019 Apr 01, 2024	BUY	$72.81 - $156.91 $106,885 - $230,343	1,468 Added 100.27%	2,932 $345 Million
Q2 2019 Apr 01, 2024	BUY	$112.21 - $151.95 $164,275 - $222,454	1,464 New	1,464 $222 Million

531

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.17B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.